Vireo Growth

About Vireo Growth

Vireo Growth Inc., operating as a vertically integrated multi-state cannabis company, has a complex history marked by several name changes, including Vireo Health and Goodness Growth Holdings. The business was first established in 2014 as Minnesota Medical Solutions. Its founder, Dr. Kyle Kingsley, a former emergency medicine physician, was motivated to enter the cannabis industry after observing patients find relief with medical cannabis, which he viewed as a safer alternative to opioids. His medical background has instilled a physician-led, science-focused approach within the company.

The company's journey began by securing one of two inaugural medical cannabis licenses in Minnesota, ranking first among a dozen applicants. This was followed by another significant milestone in 2015: winning one of only five highly competitive medical cannabis licenses in New York. Over the years, the company expanded its footprint through both organic growth and strategic acquisitions, becoming licensed in multiple states including Maryland, Arizona, and New Mexico. To fuel its expansion, the company went public on the Canadian Securities Exchange (CSE) in March 2019 through a reverse takeover transaction. In 2021, the company rebranded from Vireo Health to Goodness Growth Holdings to reflect a broader focus. A planned acquisition by Verano Holdings for $413 million was announced in February 2022 but was later terminated in October 2022. The company subsequently reverted to the name Vireo Growth Inc. in June 2024.

Vireo Growth's business model is centered on the cultivation, manufacturing, and sale of cannabis. The company operates environmentally friendly greenhouses and state-of-the-art labs to produce a variety of pharmaceutical-grade cannabis products. Its revenue is generated through the sale of these products via its own retail dispensaries—operating under brands like Green Goods and Vireo Health—and through wholesale distribution to third-party dispensaries. The product portfolio is diverse, including dry flower, concentrates, vapes, topicals, tablets, and chews under brands such as Vireo Spectrum, 1937 Cannabis, Hi-Color, and others, catering to both medical patients and adult-use consumers. The company serves qualifying patients in medical markets and adult-use consumers in states where it is permitted. In a strategic move announced in late 2024, Vireo secured significant financing and announced mergers with four single-state operators in Missouri, Nevada, Utah, and Florida, aiming to expand its national platform under a decentralized model that empowers local market leadership.